Equity Award Plans (PSO Activities) (Details) - PSOs - USD ($) $ / shares in Units, shares in Millions, $ in Millions |
9 Months Ended | 12 Months Ended |
|---|---|---|
Apr. 30, 2026 |
Jul. 31, 2025 |
|
| Number of Shares | ||
| Balance, beginning (in shares) | 1 | |
| Exercised (in shares) | (1) | |
| Balance, ending (in shares) | 0 | 1 |
| Options exercisable (in shares) | 0 | |
| Weighted-Average Exercise Price Per Share | ||
| Balance, beginning (in usd per share) | $ 32.76 | |
| Exercised (in usd per share) | 32.76 | |
| Balance, ending (in usd per share) | 0 | $ 32.76 |
| Options exercisable, weighted-average exercise price (in usd per share) | $ 0 | |
| PSOs, Additional Disclosures | ||
| Weighted-average remaining contractual life (in years) | 0 years | 6 months |
| Options exercisable, weighted-average remaining contractual term (in years) | 0 years | |
| Aggregate intrinsic value | $ 0 | $ 197 |
| Options exercisable, aggregate intrinsic value | $ 0 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period. No definition available.
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Weighted average price at which option holders acquired shares when converting their stock options into shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of share options (or share units) exercised during the current period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|